In response to a Louisiana woman’s lawsuit, Novo Nordisk said “gastrointestinal events are well known side effects” of Ozempic and asked the court to dismiss the case, according to documents filed Nov. 3.
Read the full post on Becker's Hospital Review - Healthcare News
